CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 72 filers reported holding CULLINAN ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $3,665,000 | -32.1% | 350,000 | 0.0% | 0.08% | -15.8% |
Q4 2021 | $5,401,000 | -31.6% | 350,000 | 0.0% | 0.10% | -12.8% |
Q3 2021 | $7,900,000 | -12.3% | 350,000 | 0.0% | 0.11% | -24.8% |
Q2 2021 | $9,013,000 | -38.2% | 350,000 | 0.0% | 0.14% | -34.1% |
Q1 2021 | $14,585,000 | – | 350,000 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 7,648,268 | $69,216,825 | 18.48% |
CHI Advisors LLC | 3,414,189 | $30,898,410 | 12.25% |
Nextech Invest Ltd. | 1,221,145 | $11,051,362 | 3.35% |
TANG CAPITAL MANAGEMENT LLC | 621,138 | $5,621,299 | 0.79% |
BVF INC/IL | 3,196,701 | $28,930,144 | 0.78% |
Parkman Healthcare Partners LLC | 438,745 | $3,970,642 | 0.73% |
Velan Capital Investment Management LP | 75,000 | $678,750 | 0.55% |
BRAIDWELL LP | 1,908,865 | $17,275,228 | 0.55% |
Boxer Capital, LLC | 1,074,082 | $9,720,442 | 0.52% |
DAFNA Capital Management LLC | 127,284 | $1,151,920 | 0.36% |